03/26/2024 8:11 PM | Albers Jeffrey W. (Reporting) Blueprint Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/22/2024 4:50 PM | Albers Jeffrey W. (Reporting) Blueprint Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/15/2024 4:22 PM | Blueprint Medicines (Subject) Landsittel Michael (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/15/2024 3:46 PM | Blueprint Medicines (Subject) Hurley Ariel (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/15/2024 3:47 PM | Blueprint Medicines (Issuer) Lee Philina (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/13/2024 3:17 PM | Blueprint Medicines (Subject) Lee Philina (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024 5:24 PM | Blueprint Medicines (Issuer) Murray Christopher K. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
03/11/2024 5:26 PM | Blueprint Medicines (Issuer) Lee Philina (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 5:27 PM | Blueprint Medicines (Issuer) Haviland Kate (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 5:28 PM | Blueprint Medicines (Issuer) Durso-Bumpus Debra (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 5:29 PM | Blueprint Medicines (Issuer) Hewes L. Becker (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 5:15 PM | Blueprint Medicines (Issuer) Hurley Ariel (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 5:18 PM | Blueprint Medicines (Issuer) McCain Tracey L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 5:19 PM | Blueprint Medicines (Issuer) Carter Percy H. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 5:20 PM | Blueprint Medicines (Issuer) Namouni Fouad (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 5:21 PM | Blueprint Medicines (Issuer) Rossi Christina (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 5:23 PM | Blueprint Medicines (Issuer) Landsittel Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 3:22 PM | Blueprint Medicines (Issuer) Lee Philina (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 3:15 PM | Blueprint Medicines (Issuer) Hurley Ariel (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 3:16 PM | Blueprint Medicines (Issuer) Carter Percy H. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 3:17 PM | Blueprint Medicines (Issuer) Landsittel Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 3:18 PM | Blueprint Medicines (Issuer) Haviland Kate (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 3:19 PM | Blueprint Medicines (Issuer) Hewes L. Becker (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 3:20 PM | Blueprint Medicines (Issuer) Rossi Christina (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 3:20 PM | Blueprint Medicines (Issuer) Durso-Bumpus Debra (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 3:21 PM | Blueprint Medicines (Issuer) Namouni Fouad (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 9:41 AM | Blueprint Medicines (Issuer) Murray Christopher K. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 5:19 PM | Blueprint Medicines (Subject) Murray Christopher K. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024 2:06 PM | Blueprint Medicines (Issuer) Murray Christopher K. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/28/2024 3:03 PM | Blueprint Medicines (Subject) Murray Christopher K. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/22/2024 7:20 AM | Blueprint Medicines (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/16/2024 3:40 PM | Blueprint Medicines (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/15/2024 4:26 PM | Blueprint Medicines (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/15/2024 6:05 AM | Blueprint Medicines (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2024 5:54 PM | Blueprint Medicines (Issuer) Lee Philina (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/09/2024 7:35 AM | Blueprint Medicines (Subject) FMR LLC (Filed by)
| Form SC 13G/A | |
01/29/2024 5:13 PM | Albers Jeffrey W. (Reporting) Blueprint Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/24/2024 8:46 AM | BlackRock Inc. (Filed by) Blueprint Medicines (Subject)
| Form SC 13G/A | |
01/10/2024 9:16 AM | Blueprint Medicines (Subject) VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
01/08/2024 7:03 AM | Blueprint Medicines (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/26/2023 3:24 PM | Blueprint Medicines (Issuer) Hurley Ariel (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
AI to Meet the Same Fate as EVs? (Ad) When these tech bubbles burst, they invariably leave investors disillusioned by their losses.
Now, many worry a similar fate is awaiting AI.
And one man, legendary financial analyst Porter Stansberry, who called Nvidia at $11… Simply click here to read Porter’s warning on The Big AI Die-Up now. |
12/13/2023 2:56 PM | Albers Jeffrey W. (Reporting) Blueprint Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/07/2023 5:09 PM | Blueprint Medicines (Subject) Murray Christopher K. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/06/2023 7:45 PM | Blueprint Medicines (Issuer) Murray Christopher K. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/24/2023 12:17 PM | Albers Jeffrey W. (Reporting) Blueprint Medicines (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/13/2023 8:02 AM | Blueprint Medicines (Subject) FMR LLC (Filed by)
| Form SC 13G/A | |
10/30/2023 1:01 PM | Blueprint Medicines (Issuer) Murray Christopher K. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/26/2023 6:00 AM | Blueprint Medicines (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/05/2023 9:47 AM | Blueprint Medicines (Issuer) Namouni Fouad (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/29/2023 1:36 PM | Albers Jeffrey W. (Reporting) Blueprint Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/28/2023 5:23 PM | Albers Jeffrey W. (Reporting) Blueprint Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/25/2023 7:15 AM | Blueprint Medicines (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/24/2023 3:21 PM | Albers Jeffrey W. (Reporting) Blueprint Medicines (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/02/2023 3:02 PM | Blueprint Medicines (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/02/2023 6:00 AM | Blueprint Medicines (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/30/2023 5:03 AM | Blueprint Medicines (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/23/2023 6:00 PM | Beckman Daniella (Reporting) Blueprint Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 6:02 PM | Blueprint Medicines (Issuer) Lydon Nicholas (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 6:03 PM | Blueprint Medicines (Issuer) Borisy Alexis (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 6:04 PM | Blueprint Medicines (Issuer) COATS LONNEL (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 6:04 PM | Blueprint Medicines (Issuer) Dable Habib J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 6:05 PM | Blueprint Medicines (Issuer) Tsai John (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 6:06 PM | Blueprint Medicines (Issuer) Seely Lynn (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 6:06 PM | Blueprint Medicines (Issuer) Goldberg Mark Alan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 6:07 PM | Albers Jeffrey W. (Reporting) Blueprint Medicines (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2023 6:52 PM | Blueprint Medicines (Issuer) Carter Percy H. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2023 6:48 PM | Blueprint Medicines (Issuer) Hewes L. Becker (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/22/2023 3:53 PM | Blueprint Medicines (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/04/2023 6:18 AM | Blueprint Medicines (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/28/2023 4:30 PM | Blueprint Medicines (Filer)
| Form DEF 14A | |
04/28/2023 4:30 PM | Blueprint Medicines (Filer)
| Form DEFA14A | |
03/28/2023 4:04 PM | Blueprint Medicines (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |